ibuprofen has been researched along with sc 560 in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (69.23) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, Y; Miyachi, H; Miyajima, A; Noguchi, T; Sano, H | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Jain, S; Özadalı, K; Özkanlı, F; Rao, PP; Velázquez-Martínez, CA | 1 |
| Ballatore, C; Brunden, KR; Cornec, AS; James, MJ; Kovalevich, J; Lee, VM; Makani, V; Monti, L; Oukoloff, K; Smith, AB; Trojanowski, JQ; Vijayendran, KG; Yao, Y | 1 |
| Chung, HY; Hong, J; Ju, Z; Jung, JH; Kim, S; La Kim, E; Moon, HR; Su, M | 1 |
| Dvorakova, M; Landa, P; Langhansova, L; Pavicic, A; Temml, V; Vanek, T | 1 |
| Conway, CM; Dirig, DM; Isakson, PC; Luo, ZD; Svensson, C; Yaksh, TL | 1 |
| Carter, P; Haley, M; Hefferan, MP; Loomis, CW | 1 |
| Hefferan, MP; Loomis, CW; O'Rielly, DD | 1 |
| Bari, F; Domoki, F; Nagy, K; Temesvári, P | 1 |
| Bertini, S; Bonardi, S; Coruzzi, G; Giovannini, E; Grandi, D; Menozzi, A; Pozzoli, C; Solenghi, E; Vasina, V | 1 |
| Li, W; Lin, ZY; Xu, RJ; Zhang, HH; Zhuo, GC | 1 |
| Imamura, S; Ito, K; Momma, K; Nakanishi, T; Sugiyama, K; Sun, F; Toyoshima, K | 1 |
13 other study(ies) available for ibuprofen and sc 560
| Article | Year |
|---|---|
Anti-angiogenic activity of basic-type, selective cyclooxygenase (COX)-1 inhibitors.
Topics: Angiogenesis Inhibitors; Cells, Cultured; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Endothelial Cells; Humans; Molecular Structure; Structure-Activity Relationship; Umbilical Cord | 2006 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Synthesis and biological evaluation of isoxazolo[4,5-d]pyridazin-4-(5H)-one analogues as potent anti-inflammatory agents.
Topics: Animals; Anti-Inflammatory Agents; Arachidonate 5-Lipoxygenase; Binding Sites; Catalytic Domain; Computer Simulation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Edema; Enzyme Activation; Humans; Isoxazoles; Lipoxygenase Inhibitors; Protein Binding; Pyridazines; Rats | 2012 |
Multitargeted Imidazoles: Potential Therapeutic Leads for Alzheimer's and Other Neurodegenerative Diseases.
Topics: Alzheimer Disease; Animals; Arachidonate 5-Lipoxygenase; Chemistry Techniques, Synthetic; Cyclooxygenase Inhibitors; Drug Evaluation, Preclinical; Female; Humans; Imidazoles; Leukotrienes; Lipoxygenase Inhibitors; Male; Mice, Inbred Strains; Microtubules; Molecular Targeted Therapy; Neurodegenerative Diseases; Prostaglandins; Rats; Structure-Activity Relationship | 2017 |
Design of balanced COX inhibitors based on anti-inflammatory and/or COX-2 inhibitory ascidian metabolites.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Survival; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Drug Design; Humans; Mice; Models, Molecular; Molecular Structure; RAW 264.7 Cells; Sheep; Structure-Activity Relationship; Urochordata | 2019 |
Synthesis, Inhibitory Activity, and
Topics: | 2021 |
The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperalgesia; Ibuprofen; Injections, Intraperitoneal; Injections, Spinal; Isoenzymes; Male; Membrane Proteins; N-Methylaspartate; Pain Measurement; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Sprague-Dawley; Spinal Cord; Substance P | 2001 |
Spinal nerve injury activates prostaglandin synthesis in the spinal cord that contributes to early maintenance of tactile allodynia.
Topics: Animals; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Ibuprofen; Isoenzymes; Ligation; Lumbar Vertebrae; Male; Membrane Proteins; Microdialysis; Neuralgia; Physical Stimulation; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Sprague-Dawley; Spinal Cord; Spinal Nerves; Sulfonamides; Touch | 2003 |
Inhibition of spinal prostaglandin synthesis early after L5/L6 nerve ligation prevents the development of prostaglandin-dependent and prostaglandin-independent allodynia in the rat.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Dinoprostone; Glutamic Acid; Ibuprofen; Injections, Spinal; Ligation; Male; Microdialysis; Pain; Pain Measurement; Physical Stimulation; Prostaglandin Antagonists; Prostaglandins; Pyrazoles; Rats; Rats, Sprague-Dawley; Spinal Nerves | 2003 |
Selective inhibitors differentially affect cyclooxygenase-dependent pial arteriolar responses in newborn pigs.
Topics: Acetaminophen; Animals; Animals, Newborn; Arterioles; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Female; Hypercapnia; Hypotension; Ibuprofen; Indomethacin; Male; Methacholine Chloride; Nitrobenzenes; Pia Mater; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides; Swine; Vasoconstriction; Vasodilation | 2005 |
Intestinal effects of nonselective and selective cyclooxygenase inhibitors in the rat.
Topics: Administration, Oral; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Enterobacteriaceae; Ibuprofen; Indomethacin; Intestinal Mucosa; Intestine, Small; Lipid Peroxidation; Male; Mucins; Peroxidase; Pyrazoles; Rats; Rats, Wistar; Sulfonamides | 2006 |
Effects of a cyclooxygenase-1-selective inhibitor in a mouse model of ovarian cancer, administered alone or in combination with ibuprofen, a nonselective cyclooxygenase inhibitor.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Dinoprostone; Disease Models, Animal; Female; Humans; Ibuprofen; Mice; Mice, Nude; Microvessels; Neovascularization, Pathologic; Ovarian Neoplasms; Pyrazoles; Vascular Endothelial Growth Factor A | 2009 |
Delayed neonatal closure of the ductus arteriosus following early in utero exposure to indomethacin in the rat.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Ductus Arteriosus; Ductus Arteriosus, Patent; Female; Fetus; Gestational Age; Ibuprofen; Indomethacin; Male; Maternal Exposure; Pregnancy; Pyrazoles; Rats; Rats, Wistar | 2009 |